Totally agree MSB is ticking all the boxes and doing things correctly in regard to trials etc. I guess what I'm saying is that the FDA may act with an abundance of caution going forward regardless of how well trials have been conducted and the resukts coming from them.
I can see the flip side and the point you're making that they may be eager to show they've corrected previous miscalculations with approvals. wait and see how it plays out I guess. Either way I'm a happy holder atm. hoping for a nice November though.
Elli Lilly and now Regeneron not treating advanced COIVD-19 sufferers, page-13
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |